Patents Assigned to PrecisionBiotics Group Limited
-
Publication number: 20230414681Abstract: Bifidobacterium longum strain NCIMB 41676 is useful for improving or sustaining vitality and/or reducing mental fatigue in stressful situations.Type: ApplicationFiled: August 24, 2023Publication date: December 28, 2023Applicant: PrecisionBiotics Group LimitedInventors: Eileen Frances MURPHY, Paul ENCK, Christoph BRAUN, Huiying WANG
-
Publication number: 20230405061Abstract: A combination product comprising an isolated strain of Bifidobacterium NCIMB 41003 and another strain which does not adversely interact with Bifidobacterium NCIMB 41003 improves gastrointestinal symptoms associated with IBS and improves one or more of mood, stress, anxiety, sleep quality and depression associated with IBS.Type: ApplicationFiled: July 14, 2023Publication date: December 21, 2023Applicant: PRECISIONBIOTICS GROUP LIMITEDInventors: Barry KIELY, Eileen Frances MURPHY, David GROEGER
-
Patent number: 11771723Abstract: Bifidobacterium longum strain NCIMB 41676 is useful for improving or sustaining vitality and/or reducing mental fatigue in stressful situations.Type: GrantFiled: January 29, 2019Date of Patent: October 3, 2023Assignee: PrecisionBiotics Group LimitedInventors: Eileen Frances Murphy, Paul Enck, Christoph Braun, Huiying Wang
-
Publication number: 20230210921Abstract: Bifidobacterium longum strains and cell wall fractions isolated from Bifidobacterium longum strains are useful in the prophylaxis or treatment of a respiratory viral infection in a subject. They are also useful in the prophylaxis of a secondary bacterial infection associated with a respiratory viral infection in a subject, especially a subject who is susceptible to respiratory infections.Type: ApplicationFiled: December 6, 2022Publication date: July 6, 2023Applicant: PrecisionBiotics Group LimitedInventors: Barry KIELY, Liam O'MAHONY, David GROEGER
-
Publication number: 20230146454Abstract: Lactobacillus reuteri strain having NCIMB accession number 42835 is from a novel phylogenetic clade and has unique immune-stimulatory properties and enhanced ecological performance in the human gut. A substrate for the strain, such as raffinose, may be administered at the same time as or separately from the strain.Type: ApplicationFiled: September 24, 2020Publication date: May 11, 2023Applicant: PRECISIONBIOTICS GROUP LIMITEDInventor: Jens WALTER
-
Patent number: 11590179Abstract: Bifidobacterium longum strains and cell wall fractions isolated from Bifidobacterium longum strains are useful in the prophylaxis or treatment of a respiratory viral infection in a subject. They are also useful in the prophylaxis of a secondary bacterial infection associated with a respiratory viral infection in a subject, especially a subject who is susceptible to respiratory infections.Type: GrantFiled: February 28, 2018Date of Patent: February 28, 2023Assignee: PrecisionBiotics Group LimitedInventors: Barry Kiely, Liam O'Mahony, David Groeger
-
Patent number: 11529381Abstract: An isolated strain of Bifidobacterium longum NCIMB 42020 is useful for the treatment of viral infections, especially viral respiratory infections such as influenza, rhinovirus and RSV. Bifidobacterium longum NCIMB 42020 is also useful for clearing secondary bacterial infections.Type: GrantFiled: February 28, 2018Date of Patent: December 20, 2022Assignee: PrecisionBiotics Group LimitedInventors: Barry Kiely, Liam O'Mahony, David Groeger
-
Publication number: 20220387523Abstract: A combination product comprising an isolated strain of Bifidobacterium NCIMB 41003 and another strain which does not adversely interact with Bifidobacterium NCIMB 41003 improves gastrointestinal symptoms associated with IBS and improves one or more of mood, stress, anxiety, sleep quality and depression associated with LBS.Type: ApplicationFiled: June 17, 2022Publication date: December 8, 2022Applicant: PRECISIONBIOTICS GROUP LIMITEDInventors: Barry KIELY, Eileen Frances Murphy, David Groeger
-
Patent number: 11490643Abstract: The strain Lactobacillus casei AH077 (NCIMB12019) produces a polysaccharide and increases energy excretion. The strain acts to block fat absorption and is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.Type: GrantFiled: March 30, 2021Date of Patent: November 8, 2022Assignee: PrecisionBiotics Group LimitedInventors: Barry Kiely, Eileen Frances Murphy, Selena Healy
-
Patent number: 11400123Abstract: A combination product comprising an isolated strain of Bifidobacterium NCIMB 41003 and another strain which does not adversely interact with Bifidobacterium NCIMB 41003 improves gastrointestinal symptoms associated with IBS and improves one or more of mood, stress, anxiety, sleep quality and depression associated with IBS.Type: GrantFiled: January 29, 2019Date of Patent: August 2, 2022Assignee: PrecisionBiotics Group LimitedInventors: Barry Kiely, Eileen Frances Murphy, David Groeger
-
Publication number: 20220169976Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.Type: ApplicationFiled: December 8, 2021Publication date: June 2, 2022Applicant: PRECISIONBIOTICS GROUP LIMITEDInventors: Liam O'Mahony, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
-
Patent number: 11225641Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.Type: GrantFiled: February 13, 2020Date of Patent: January 18, 2022Assignee: PrecisionBiotics Group LimitedInventors: Liam O'Mahony, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
-
Publication number: 20210282444Abstract: The strain Lactobacillus casei AH077 (NCIMB12019) produces a polysaccharide and increases energy excretion. The strain acts to block fat absorption and is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.Type: ApplicationFiled: March 30, 2021Publication date: September 16, 2021Applicant: PrecisionBiotics Group LimitedInventors: Barry KIELY, Eileen Frances MURPHY, Selena HEALY
-
Publication number: 20210163878Abstract: The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.Type: ApplicationFiled: December 14, 2020Publication date: June 3, 2021Applicants: PrecisionBiotics Group Limited, University College Cork, National University of Ireland, Teagasc - The Agriculture and Food Development AuthorityInventors: Liam O'Mahony, Fergus Shanahan, Eamonn Quigley, Paul Ross, Catherine Stanton
-
Publication number: 20210127695Abstract: Bifidobacterium longum strain NCIMB 41676 improves sleep.Type: ApplicationFiled: September 4, 2020Publication date: May 6, 2021Applicants: PrecisionBiotics Group Limited, University College Cork - National University of Ireland, CorkInventors: Eileen Frances MURPHY, David GROEGER, Timothy DINAN, John CRYAN
-
Patent number: 10973862Abstract: Bifidobacterium longum AH1362 (NCIMB 41715) produces a polysaccharide and increases energy excretion. The strain is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.Type: GrantFiled: December 9, 2016Date of Patent: April 13, 2021Assignee: PrecisionBiotics Group LimitedInventors: Barry Kiely, Eileen Frances Murphy, Selena Healy
-
Publication number: 20200377961Abstract: The multiple embodiments described herein comprise the genome of a probiotic Bifidobacterium longum bifidobacteria strain and genes encoded by the genome. Various novel Bifidobacterium longum are described.Type: ApplicationFiled: May 12, 2020Publication date: December 3, 2020Applicant: PrecisionBiotics Group LimitedInventors: Douwe Van Sinderen, Jun Xu, Wenzhu Zhao, Raymond A. Grant, Yuli Song, Charles Bascom, Duane Larry Charbonneau, Liam O'Mahony
-
Patent number: 10813366Abstract: Methods of treating a subject by administering Bifidobacterium longum strain NCIMB 41676 are discussed. The method may include orally administering a formulation comprising Bifidobacterium longum strain NCIMB 41676 to improve sleep.Type: GrantFiled: February 18, 2020Date of Patent: October 27, 2020Assignees: PrecisionBiotics Group Limited, University College Cork—National University of Ireland, CorkInventors: Eileen Frances Murphy, David Groeger, Timothy Dinan, John Cryan
-
Publication number: 20200325548Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.Type: ApplicationFiled: February 13, 2020Publication date: October 15, 2020Applicant: PRECISIONBIOTICS GROUP LIMITEDInventors: Liam O'MAHONY, Barry KIELY, John Francis CRYAN, Timothy DINAN, Eileen Frances MURPHY
-
Patent number: 10689719Abstract: The multiple embodiments described herein comprise the genome of a probiotic Bifidobacterium longum bifidobacteria strain and genes encoded by the genome. Various novel Bifidobacterium longum are described.Type: GrantFiled: August 23, 2017Date of Patent: June 23, 2020Assignee: PrecisionBiotics Group LimitedInventors: Douwe Van Sinderen, Jun Xu, Wenzhu Zhao, Raymond A. Grant, Yuli Song, Charles Bascom, Duane Larry Charbonneau, Liam O'Mahony
